SPONSOR
Huashan Hospital
Total Trials
8
Recruiting
8
Phases
Phase 3
Conditions studied: Salivary Gland CancersPatient Derived OrganoidDrug Sensitive Test in VitroMultidrug Resistant TuberculosisRifampicin Resistant TuberculosisPre-XDR-TBRectal CancerTuberculosisLatent Tuberculosis InfectionHepatitis B, Chronic
Huashan Hospital is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Salivary Gland Cancers, Patient Derived Organoid, Drug Sensitive Test in Vitro, Multidrug Resistant Tuberculosis.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Huashan Hospital
How many clinical trials has Huashan Hospital sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Huashan Hospital, of which 8 are actively recruiting participants. These trials cover conditions including Salivary Gland Cancers, Patient Derived Organoid, Drug Sensitive Test in Vitro. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Huashan Hospital research focus on?
Huashan Hospital clinical trials span Salivary Gland Cancers, Patient Derived Organoid, Drug Sensitive Test in Vitro, Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Huashan Hospital clinical trial?
To participate in a Huashan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Huashan Hospital trials with current recruitment status updated daily.
Clinical Trials by Huashan Hospital
NCT06686979
Recruiting
PDO Based Drug Sensitive Test in R/M SGC
Salivary Gland Cancers
NCT05081401 Phase 3
Recruiting
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
Multidrug Resistant Tuberculosis
NCT07369830
Recruiting
The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
Rectal Cancer
NCT06033807
Recruiting
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Tuberculosis
NCT06550622
Recruiting
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
Hepatitis B, Chronic
NCT05387369
Recruiting
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
COVID-19
NCT06022146 Phase 3
Recruiting
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Tuberculosis
NCT06679244
Recruiting
Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study
Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology